BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24740154)

  • 1. Genome-wide association scan for variants associated with early-onset prostate cancer.
    Lange EM; Johnson AM; Wang Y; Zuhlke KA; Lu Y; Ribado JV; Keele GR; Li J; Duan Q; Li G; Gao Z; Li Y; Xu J; Isaacs WB; Zheng S; Cooney KA
    PLoS One; 2014; 9(4):e93436. PubMed ID: 24740154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genome-wide association study of prostate cancer in Latinos.
    Du Z; Hopp H; Ingles SA; Huff C; Sheng X; Weaver B; Stern M; Hoffmann TJ; John EM; Van Den Eeden SK; Strom S; Leach RJ; Thompson IM; Witte JS; Conti DV; Haiman CA
    Int J Cancer; 2020 Apr; 146(7):1819-1826. PubMed ID: 31226226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of rs6983561 polymorphism at 8q24 with prostate cancer mortality in a Japanese population.
    Suzuki M; Liu M; Kurosaki T; Suzuki M; Arai T; Sawabe M; Kasuya Y; Kato M; Fujimura T; Fukuhara H; Enomoto Y; Nishimatsu H; Ishikawa A; Kume H; Homma Y; Kitamura T
    Clin Genitourin Cancer; 2011 Sep; 9(1):46-52. PubMed ID: 21700508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 17q12 variants contribute to risk of early-onset prostate cancer.
    Levin AM; Machiela MJ; Zuhlke KA; Ray AM; Cooney KA; Douglas JA
    Cancer Res; 2008 Aug; 68(16):6492-5. PubMed ID: 18701471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 8q24 and 17q risk loci and prostate cancer mortality.
    Penney KL; Salinas CA; Pomerantz M; Schumacher FR; Beckwith CA; Lee GS; Oh WK; Sartor O; Ostrander EA; Kurth T; Ma J; Mucci L; Stanford JL; Kantoff PW; Hunter DJ; Stampfer MJ; Freedman ML
    Clin Cancer Res; 2009 May; 15(9):3223-30. PubMed ID: 19366828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies.
    Ishak MB; Giri VN
    Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1599-610. PubMed ID: 21715604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review of Prostate Cancer Genome-Wide Association Studies (GWAS).
    Benafif S; Kote-Jarai Z; Eeles RA;
    Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):845-857. PubMed ID: 29348298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the Cumulative Contribution of New and Established Common Genetic Risk Factors to Early-Onset Prostate Cancer.
    Lange EM; Ribado JV; Zuhlke KA; Johnson AM; Keele GR; Li J; Wang Y; Duan Q; Li G; Gao Z; Li Y; Xu J; Zheng SL; Cooney KA
    Cancer Epidemiol Biomarkers Prev; 2016 May; 25(5):766-72. PubMed ID: 26671023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association study of prostate cancer mortality.
    Penney KL; Pyne S; Schumacher FR; Sinnott JA; Mucci LA; Kraft PL; Ma J; Oh WK; Kurth T; Kantoff PW; Giovannucci EL; Stampfer MJ; Hunter DJ; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2869-76. PubMed ID: 20978177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication of the 10q11 and Xp11 prostate cancer risk variants: results from a Utah pedigree-based study.
    Camp NJ; Farnham JM; Wong J; Christensen GB; Thomas A; Cannon-Albright LA
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1290-4. PubMed ID: 19336566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer.
    FitzGerald LM; Kwon EM; Conomos MP; Kolb S; Holt SK; Levine D; Feng Z; Ostrander EA; Stanford JL
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1196-203. PubMed ID: 21467234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8q24 and prostate cancer: association with advanced disease and meta-analysis.
    Cheng I; Plummer SJ; Jorgenson E; Liu X; Rybicki BA; Casey G; Witte JS
    Eur J Hum Genet; 2008 Apr; 16(4):496-505. PubMed ID: 18231127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence.
    Ahn J; Kibel AS; Park JY; Rebbeck TR; Rennert H; Stanford JL; Ostrander EA; Chanock S; Wang MH; Mittal RD; Isaacs WB; Platz EA; Hayes RB
    Clin Cancer Res; 2011 Mar; 17(5):1075-81. PubMed ID: 21343373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early onset prostate cancer has a significant genetic component.
    Lange EM; Salinas CA; Zuhlke KA; Ray AM; Wang Y; Lu Y; Ho LA; Luo J; Cooney KA
    Prostate; 2012 Feb; 72(2):147-56. PubMed ID: 21538423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication study of 34 common SNPs associated with prostate cancer in the Romanian population.
    Jinga V; Csiki IE; Manolescu A; Iordache P; Mates IN; Radavoi D; Rascu S; Badescu D; Badea P; Mates D
    J Cell Mol Med; 2016 Apr; 20(4):594-600. PubMed ID: 26773531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese.
    Akamatsu S; Takata R; Haiman CA; Takahashi A; Inoue T; Kubo M; Furihata M; Kamatani N; Inazawa J; Chen GK; Le Marchand L; Kolonel LN; Katoh T; Yamano Y; Yamakado M; Takahashi H; Yamada H; Egawa S; Fujioka T; Henderson BE; Habuchi T; Ogawa O; Nakamura Y; Nakagawa H
    Nat Genet; 2012 Feb; 44(4):426-9, S1. PubMed ID: 22366784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic sequence variants are associated with severity of lower urinary tract symptoms and prostate cancer susceptibility.
    Helfand BT; Hu Q; Loeb S; McVary KT; Catalona WJ
    J Urol; 2013 Mar; 189(3):845-8. PubMed ID: 23159463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of common prostate cancer risk variants in an unscreened Romanian population.
    Iordache PD; Mates D; Gunnarsson B; Eggertsson HP; Sulem P; Guðmundsson J; Benónísdóttir S; Csiki IE; Rascu S; Radavoi D; Ursu R; Staicu C; Calota V; Voinoiu A; Jinga M; Rosoga G; Danau R; Sima SC; Badescu D; Suciu N; Radoi V; Manolescu A; Rafnar T; Halldórsson BV; Jinga V; Stefánsson K
    J Cell Mol Med; 2018 Mar; 22(3):1574-1582. PubMed ID: 29266682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype.
    Rogler A; Rogenhofer M; Borchardt A; Lunz JC; Knoell A; Hofstaedter F; Tannapfel A; Wieland W; Hartmann A; Stoehr R
    Pathobiology; 2011; 78(4):193-200. PubMed ID: 21778786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple newly identified loci associated with prostate cancer susceptibility.
    Eeles RA; Kote-Jarai Z; Giles GG; Olama AA; Guy M; Jugurnauth SK; Mulholland S; Leongamornlert DA; Edwards SM; Morrison J; Field HI; Southey MC; Severi G; Donovan JL; Hamdy FC; Dearnaley DP; Muir KR; Smith C; Bagnato M; Ardern-Jones AT; Hall AL; O'Brien LT; Gehr-Swain BN; Wilkinson RA; Cox A; Lewis S; Brown PM; Jhavar SG; Tymrakiewicz M; Lophatananon A; Bryant SL; ; ; ; Horwich A; Huddart RA; Khoo VS; Parker CC; Woodhouse CJ; Thompson A; Christmas T; Ogden C; Fisher C; Jamieson C; Cooper CS; English DR; Hopper JL; Neal DE; Easton DF
    Nat Genet; 2008 Mar; 40(3):316-21. PubMed ID: 18264097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.